Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finalgon Cream in Acute Low Back Pain
NCT02300311Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2015
- Primary completion
- May 2015
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of nonivamide + nicoboxil in acute low back pain, sponsored by Boehringer Ingelheim. Started Jan 2015; status: completed.
02
Drugs
nonivamide + nicoboxil
03
Conditions
acute low back pain
Beyond the preview
Go deeper on NCT02300311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02300311.